Brief: Xeris Biopharma Q1 product revenue USD 32.265 million
09/05/2023 13:27
May 9 (Reuters) - Xeris Biopharma Q1 basic EPS USD -0.12. * Q1 product revenue USD 32.265 million * Q1 net income USD -16.834 million * Q1 operating income USD -13.277 million
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest